Pharmaceuticals

FDA grants accelerated approval to Amgen’s Imdeltora to treat adults with advanced small cell lung cancer

bexib
By bexib 0 Min Read

Imdelltra (tarlatamab-dlle) is the first T-cell engager therapy approved for extensive-stage small cell lung cancer.

You Might Also Like

Genomics Expands Partnership with Vertex Pharmaceuticals

New Study Finds Digital Health Technologies Providing Benefits for Payers

Pharma Pulse 8/20/24: CRAACO Evolution, Pain Relief for HIV-Infected People and More

Coloplast launches Heylo, a digital leak notification system for stoma patients

Opposite Spectrum

Share This Article
Previous Article The best email marketing tells a story
Next Article Exciting American-themed bar and restaurant opens in Liverpool’s iconic cultural quarter
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

New direction for the U.S. Senate Budget Committee
Insurance
How to print a shipping label
International Shipping
5 Content Marketing Ideas for February 2025
Retail & E-commerce
IT Spending in 2025: Cybersecurity – Bank Automation News
Banking